Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Chemcel Biotech IPO.
March 15, 2024 9:37:00 AM
While there may be exceptions and individual stock performances can vary widely, the first-day trading behavior of IPOs often provides insight into the long-term prospects of the biotech sector.
Published by : The UBJ on MSNMarch 14, 2024 2:33:00 PM
with IPO funding of more than $1.2 billion so far this quarter still far below precrash levels, Jefferies data show. That might be a sign that conditions are ideal for investing in new biotech ...
Published by : The Wall Street Journal on MSNApril 3, 2024 12:30:00 PM
The first quarter saw a hopeful glimmer in the IPO markets with a handful of companies announcing plans to take the plunge. The largest was CG Oncology, which had a total transaction value of $380 ...
Published by : FierceBiotechMarch 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechMay 5, 2017 2:39:00 PM
The biotech IPO market seems to be heating up after three stock market launches in quick succession, including the largest launch seen in the sector this year. After a boom in 2014 and 2015 ...
Published by : pharmaphorumMarch 29, 2024 3:30:00 AM
It has shown the same promise among people with general obesity. The San Diego-based biotech is close to completing a pre-IPO financing round in which it will raise between $75mn and $100mn from a ...
Published by : The Financial TimesMay 19, 2020 3:30:00 AM
Legend Biotech is spinning out from parent firm GenScript Biotech to pursue treatments in CAR T cell therapies for multiple myeloma. Legend Biotech is spinning out from parent firm GenScript ...
Published by : TheStreet.comMay 5, 2023 3:30:00 AM
The company raised $540 million from the sale of 30 million shares at $18 apiece, in the largest biotech IPO in the US since Sana Biotech went public in early 2021 with a $588 million raise that ...
Published by : pharmaphorumMarch 1, 2023 9:16:00 PM
We have audited the attached Balance sheet of CHEMCEL BIOTECH LIMITED as at 31st March, 2011 and related Profit and Loss account of the Company for the year ended on that date annexed thereto.
Published by : India InfolineApril 4, 2024 3:30:00 AM
Contineum�s offering keeps biotech IPOs on their strongest pace in three years, according to BioPharma Dive data. By this time last year, only four drug startups had gone public, raising $375 ...
Published by : Yahoo FinanceOctober 12, 2023 9:50:00 PM
After a decade of significant challenges, biotech's long-term sustainability depends on making fundamental changes to its traditional business model. A commonly held perception in the biotech ...
Published by : NatureMarch 21, 2024 6:34:00 PM
Laura Chico, Senior VP at Wedbush, is optimistic about 2024 biotech IPO market and M&A trends. As the U.S. heads into an election year, the biotech sector often faces uncertainty that can impact ...
Published by : Benzinga.comChemcel Biotech Limited IPO stock listed today at a huge discount of around 68%. An Agro Chemicals manufacturer's fixed price IPO was priced at Rs 16 and closed for subscription on September 12.
Chemcel stock opened at its issue price of Rs 16 and then keeps falling all day. At one point the stock went down to its day low of Rs 4.75. Later the stock recovered a little and finally closed at Rs 5.25, around -68% from its issue price.
Most of the experts told investors not to apply in this IPO. The grey market premiums were running at Rs 2 to Rs 3 just before its listing.
Chemcel Biotech IPO Listing Date & Info:
IPO Listing Date: Monday, October 13, 2008
BSE Script Code: 533026
Listing in: 'B' Group of Securities
ISIN: INE213J01012
Issue Price: Rs 16/- Per Equity Share
Face Value: Rs 10/- Per Equity Share
IPO Allotment Status is now available online for Chemcel Biotech Limited IPO.
Chemcel Biotech IPO was open on September 09, 2008 and closed on September 12, 20.
The Chemcel Biotech IPO is proposed to open on September 9, 2008. The IPO application ends on September 12, 2008.
Retail investors can apply in the retail or non-institutional investor category from September 9, 2008 to September 12, 2008. The Chemcel Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Chemcel Biotech IPO will open for subscription on September 9, 2008. The public issue will close on September 12, 2008.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
DRHP
